Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Head and Neck Cancer
Both
Head and Neck Cancer
Trial Information
Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer
Inclusion Criteria:
- Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma
involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node
metastasis from unknown origin
- Scheduled to receive radiotherapy and/or drug therapy including chemotherapy,
biologic therapy and targeted therapy
- Written informed consent
Exclusion Criteria:
- Registry participation does not exclude participation in clinical trials.
- Patients scheduled to receive or who have received surgery are eligible for Registry
participation as long as they are also scheduled to receive medical therapy.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Patterns of care for head and neck cancer
Outcome Time Frame:
up to 10 years
Safety Issue:
No
Principal Investigator
Mednet Solutions
Investigator Role:
Study Director
Investigator Affiliation:
Mednet Solutions
Authority:
United States: Food and Drug Administration
Study ID:
13440
NCT ID:
NCT01080313
Start Date:
August 2005
Completion Date:
December 2011
Related Keywords:
- Head and Neck Cancer
- Head and Neck Neoplasms
Name | Location |
|---|---|
| Mednet Solutions | Minnetonka, Minnesota 55305 |
